BioXcel Therapeutics, Inc. - Common Stock (NQ:BTAI)

NASDAQ: BTAI Investor Notice Lawsuit Alleges Securities Laws Violations by BioXcel Therapeutics, Inc. ↗

August 11, 2023

San Diego, CA -- (SBWIRE) -- 08/11/2023 -- An investor, who purchased shares of BioXcel Therapeutics, Inc. (NASDAQ: BTAI), filed a lawsuit over alleged violations of Federal Securities Laws by BioXcel...

Via SBWire

Topics Lawsuit

A Preview Of BioXcel Therapeutics's Earnings ↗

August 11, 2023

Via Benzinga

ROSEN, A LEADING NATIONAL FIRM, Encourages BioXcel Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BTAI

August 08, 2023

WHY: New York, NY - (NewMediaWire) - August 08, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) between December...

BIOXCEL THERAPEUTICS, INC. (NASDAQ: BTAI) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against BioXcel Therapeutics, Inc.

Topics Lawsuit

Analyst Ratings for BioXcel Therapeutics ↗

July 17, 2023

Via Benzinga

August 08, 2023

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioXcel, Seagate, Baxter, and Danaher and Encourages Investors to Contact the Firm

August 06, 2023

From Bragar Eagel & Squire

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in BioXcel Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

August 06, 2023

Via ACCESSWIRE

Lost Money in BioXcel Therapeutics, Inc? Gibbs Law Group Investigates Potential Securities Law Violations

August 01, 2023

From Gibbs Law Group

BTAI DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against BioXcel Therapeutics, Inc.

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 01, 2023

Via Benzinga

August 01, 2023

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Seagate, Baxter, and BioXcel and Encourages Investors to Contact the Firm

July 31, 2023

From Bragar Eagel & Squire

BYND, BTAI, and ALLO stand out as high short-interest stocks to watch due to their potential for price fluctuations and short-squeeze opportunities.

3 Stocks With Sky-High Short Interest Levels

July 31, 2023

Via MarketBeat

BIOXCEL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against BioXcel Therapeutics, Inc. and Encourages Investors to Contact the Firm

July 27, 2023

From Bragar Eagel & Squire, P.C.

BIOXCEL THERAPEUTICS, INC. (NASDAQ: BTAI) SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against BioXcel Therapeutics, Inc.

July 25, 2023

ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioXcel Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BTAI

July 24, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

ROSEN, A TOP RANKED LAW FIRM, Encourages BioXcel Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BTAI

Topics Lawsuit

July 21, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in BioXcel Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

Topics Lawsuit

July 19, 2023

From The Schall Law Firm

BioXcel Therapeutics, Inc. (BTAI) Class Action Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against BioXcel Therapeutics, Inc.

July 18, 2023

From Robbins LLP

July 18, 2023

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages BioXcel Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BTAI

July 17, 2023

From The Rosen Law Firm PA

ROSEN, A RESPECTED AND LEADING FIRM, Encourages BioXcel Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BTAI

Benzinga's Top Ratings Upgrades, Downgrades For July 17, 2023 ↗

July 17, 2023

Via Benzinga

July 16, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioXcel Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BTAI

Topics Lawsuit

July 15, 2023

WHY: New York, NY - (NewMediaWire) - July 15, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) between December...

Lost Money in BioXcel Therapeutics, Inc? Gibbs Law Group Investigates Potential Securities Law Violations

Topics Lawsuit

July 14, 2023

From Gibbs Law Group

ROSEN, A LEADING AND RANKED FIRM, Encourages BioXcel Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BTAI

July 14, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages BioXcel Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BTAI

Topics Lawsuit

July 13, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Calling All BioXcel Therapeutics, Inc. (BTAI) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses!

Topics Lawsuit

July 13, 2023

From Bronstein, Gewirtz & Grossman, LLC

With the Street generally bearish towards the biotech sector, investors need to identify biotech stocks to avoid at this point.

3 Biotech Stocks to Sell Before They Damage Your Portfolio ↗

July 12, 2023

Via InvestorPlace

Calling All BioXcel Therapeutics, Inc. (BTAI) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses!

July 12, 2023

From Bronstein, Gewirtz & Grossman, LLC